MedTrace Logo

Triathlon Tritanium Knee Outcomes Study

NCT02155712 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2023-11-14

Study results available
· View outcomes & findings →

Summary

The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.

Conditions

  • Arthroplasty, Replacement, Knee

Interventions

DEVICE

Triathlon Tritanium Knee

Cementless

DEVICE

Triathlon Knee

Cemented

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Edward Petrow, DO · Tucson Orthopaedic Institute

  • Alvin Ong, MD · Rothman Orthopaedic Institute

  • David Heekin, MD · Heekin Clinic

  • Kipling Sharpe, MD · OrthoArizona

  • Marcus Barnett, MD · Mission Hospital Research Institute

  • John Noble, MD · Imperial Health

  • Michael Masini, MD · St. Joseph Mercy Health System

  • Samuel Wellman, MD · Duke University

  • Ronald Delanois, MD · Sinai Hospital of Baltimore

  • Thomas Bowen, MD · Geisinger Orthopaedic Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-04-05
Completion
2023-03-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155712 on ClinicalTrials.gov